Search details
1.
Extracellular Nucleotides Affect the Proangiogenic Behavior of Fibroblasts, Keratinocytes, and Endothelial Cells.
Int J Mol Sci
; 23(1)2021 Dec 27.
Article
in English
| MEDLINE | ID: mdl-35008664
2.
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib.
Mediators Inflamm
; 2020: 1835836, 2020.
Article
in English
| MEDLINE | ID: mdl-32587468
3.
[Watching dance of the molecules - CARS microscopy]. / Obserwujac tanczace molekuly - mikroskopia CARS.
Postepy Biochem
; 63(1): 44-52, 2017.
Article
in Polish
| MEDLINE | ID: mdl-28409574
4.
Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.
J Clin Med
; 11(1)2021 Dec 26.
Article
in English
| MEDLINE | ID: mdl-35011853
5.
The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib.
Cancers (Basel)
; 13(5)2021 Feb 25.
Article
in English
| MEDLINE | ID: mdl-33668794
6.
The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.
Cancers (Basel)
; 12(9)2020 Sep 09.
Article
in English
| MEDLINE | ID: mdl-32916955
7.
Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.
Oncotarget
; 7(43): 69358-69370, 2016 Oct 25.
Article
in English
| MEDLINE | ID: mdl-27732965
8.
Proangiogenic properties of nucleoside 5'-O-phosphorothioate analogues under hyperglycaemic conditions.
Curr Top Med Chem
; 15(23): 2464-74, 2015.
Article
in English
| MEDLINE | ID: mdl-26088349
Results
1 -
8
de 8
1
Next >
>>